x
Speaker Details
Full Name
David Cella
Speaking At
ORAL ABSTRACT: Exploring and identifying differences in characteristics and outcomes between patients receiving cabozantinib plus nivolumab (CaboNivo) and sunitinib in CheckMate 9ER (CM9ER): a latent class analysis
